Baptist Cardiovascular Surgeon Discusses Results of Stroke Prevention Trial

The results of the CREST trial have been completed. Baptist was selected as one of 117 sites in the United States and Canada and the only site in Mississippi to participate in this study helping physicians find a better way to prevent strokes in people who have a narrowing in the carotid artery.
This study is referred to as the CREST Trial, which stands for Carotid Revascularization Endarterectomy vs. Stenting Trials. The Neurological Disorders and Stroke section of the National Institutes of Health and the Food and Drug Administration sponsored research. The study compared carotid endarterectomy, a common operation to prevent stroke, to a minimally invasive procedure, called carotid artery stenting.

2,502 patients participated in the CREST study and received either carotid endarterectomy or carotid artery stenting to treat the narrowed area in their carotid artery. Cardiovascular Surgeon Charles OMara, MD with the Cardiovascular Surgical Clinic, served as Baptists primary investigator for the study, and Baptist Cardiovascular Diagnostic Director Judy Henderson, RN, served as the study clinical coordinator.

Carotid Revascularization Endarterectomy versus Stenting Trial detemined both coronary artery stenting (CAS) and carotid endarterectomy (CEA) have similar overall net outcomes fro the treatment of carotid stenosis, when the procedures are done in settings where both physicians and facilities have been fully vetted fro providing quality carotid disease management.

Category:

Science & Technology

Tags:

• stroke trial
• CREST Trial
• stroke prevention
• carotid endarterectomy
• Baptist Health Systems
• Baptist Medical Center
• stroke